Director, Global RWE-HO, Oncology
Leads the design and execution of real-world evidence and health outcomes studies to support oncology assets, ensuring robust data generation for regulatory, reimbursement, and market access decisions. Collaborates across medical, commercial, and R&D teams to align evidence strategies with global customer needs and health technology assessment requirements. Engages with external experts and internal stakeholders to deliver high-impact scientific research throughout the product lifecycle.